The use of smokeless tobacco products has been associated with an increased incidence of oral inflammation. However, the mechanisms underlying the pro-inflammatory effects of nicotine are unknown. Our preliminary studies indicate that nicotinic receptors are present on sensory neurons and that nicotine potentiates the evoked release of immunoreactive calcitonin gene related peptide (i-CGRP), a neuropeptide known to possess pro-inflammatory properties. These data provide a molecular basis for the ability of nicotine to influence the development of neurogenic inflammation. The multidisciplinary studies proposed here, therefore, will attempt to elucidate the molecular and pharmacological mechanisms whereby nicotine modulates peripheral neuronal function. The proposed research will: 1. Characterize pharmacologically neuronal nicotinic receptors in the trigeminal ganglion. 2. Identify the subunit composition of nicotinic receptor subtypes that are present in the trigeminal ganglion. 3. Determine the mechanisms by which nicotine alters evoked release of iCGRP from sensory neurons. 4. Determine the effect of chronic nicotine treatment on neuronal nicotinic receptor subtype expression in the trigeminal ganglion. 5. Determine the effect of chronic nicotine treatment on the ability of nicotine to alter evoked release of iCGRP from peripheral sensory neurons. Collectively, these specific aims will test the hypothesis that nicotine, acting at the level of the primary sensory neuron, is capable of modulating the development of neurogenic inflammation. To this end, we have developed a model for studying the ability of nicotine to modulate neurogenic inflammation in oral mucosal tissue. As first point of exposure to nicotine with the use of smokeless tobacco as well as cigarettes, the buccal mucosa offer significant, biomedically relevant advantages as a model system for investigations aimed at elucidating the various effects of nicotine in humans. Additionally, with the use of specific pharmacological, immunological and molecular probes for nicotinic receptors, the results should be able to contribute to a basic understanding on a biochemical level for the effects of nicotine on sensory neurons.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA010510-03
Application #
2749149
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Thomas, David D
Project Start
1996-09-10
Project End
2001-07-31
Budget Start
1998-08-01
Budget End
1999-07-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Dentistry
Type
Schools of Dentistry
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Price, Theodore J; Flores, Christopher M (2007) Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities, and isolectin B4 binding in primary afferent neurons of the rat and mouse. J Pain 8:263-72
Dussor, G O; Jones, D J; Hulsebosch, C E et al. (2005) The effects of chemical or surgical deafferentation on [3H]-acetylcholine release from rat spinal cord. Neuroscience 135:1269-76
Dussor, Gregory O; Helesic, Gabriela; Hargreaves, Kenneth M et al. (2004) Cholinergic modulation of nociceptive responses in vivo and neuropeptide release in vitro at the level of the primary sensory neuron. Pain 107:22-32
Dussor, Gregory O; Leong, Anthony S; Gracia, Nicholas B et al. (2003) Potentiation of evoked calcitonin gene-related peptide release from oral mucosa: a potential basis for the pro-inflammatory effects of nicotine. Eur J Neurosci 18:2515-26
Dussor, Gregory O; Price, Theodore J; Flores, Christopher M (2003) Activating transcription factor 3 mRNA is upregulated in primary cultures of trigeminal ganglion neurons. Brain Res Mol Brain Res 118:156-9
Gilbert, S D; Clark, T M; Flores, C M (2001) Antihyperalgesic activity of epibatidine in the formalin model of facial pain. Pain 89:159-65
Flores, C M; Leong, A S; Dussor, G O et al. (2001) Capsaicin-evoked CGRP release from rat buccal mucosa: development of a model system for studying trigeminal mechanisms of neurogenic inflammation. Eur J Neurosci 14:1113-20
Ulrich-Lai, Y M; Flores, C M; Harding-Rose, C A et al. (2001) Capsaicin-evoked release of immunoreactive calcitonin gene-related peptide from rat trigeminal ganglion: evidence for intraganglionic neurotransmission. Pain 91:219-26
Flores, C M; Wilson, S G; Mogil, J S (1999) Pharmacogenetic variability in neuronal nicotinic receptor-mediated antinociception. Pharmacogenetics 9:619-25
Flores, C M; Davila-Garcia, M I; Ulrich, Y M et al. (1997) Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J Neurochem 69:2216-9

Showing the most recent 10 out of 13 publications